Abstract
IT is customary, in prolonging the survival of homografts with a chemical agent, to give frequent doses of the agent over a prolonged period. Effective agents are generally toxic, and their use is attended by considerable mortality, in both laboratory animals and man. The immune response is not uniformly susceptible to inhibition by these agents throughout its course1, nor is it uniformly active. It is likely, therefore, that dose-schedules not closely adapted to this changing sensitivity and activity of the immune response may, on one hand, subject the recipient to unnecessary toxicity and, on the other, fail to attack the immune response sufficiently during its most vulnerable period. It is therefore of some importance to establish the principles on which optimum dose-schedules may be based.
Similar content being viewed by others
Article PDF
References
Berenbaum, M. C., Biochem. Pharmacol., 11, 29 (1962). Frisch, A. W., Davies, G. H., and Milstein, V., J. Immunol., 89, 300 (1962). Malmgren, R. A., Bennison, B. E., and McKinley, T. W., J. Nat. Cancer Inst., 12, 807 (1952). Schwartz, R., Stack, J., and Damashek, W., Proc. Soc. Exp. Biol., 99, 164 (1958). Stender, H., Strauch, D., and Winter, H., Strahlentherapie, 115, 175 (1961).
Berenbaum, M. C., and Brown, I. N., Immunol. (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BERENBAUM, M., BROWN, I. Prolongation of Homograft Survival in Mice with Single Doses of Cyclophosphamide. Nature 200, 84 (1963). https://doi.org/10.1038/200084a0
Issue Date:
DOI: https://doi.org/10.1038/200084a0
This article is cited by
-
Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
Bone Marrow Transplantation (2020)
-
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
Bone Marrow Transplantation (2020)
-
Halfway there: the past, present and future of haploidentical transplantation
Bone Marrow Transplantation (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.